Repligen Stock Widgets and Gadgets
| RGEN Stock | USD 171.28 13.80 8.76% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- RGEN Repligen
- Latest Global Cell Expansion Market Landscape 2024-2029 Featuring Analysis of Thermo Fisher Scientific, Danaher Corp, Merck, Sartorius, Corning, and More
- RGEN 171.28 13.8
- Low 165.44
- High 174.3
- Volume 928.6 K
- Alpha -0.3
- Beta 1.99
- Return On Equity 0.0214
- Return On Asset 0.0131
- Profit Margin 0.07 %
- Operating Margin 0.05 %
- Current Valuation 8.74 B
- Shares Outstanding 55.84 M
- Shares Owned By Insiders 6.59 %
- Shares Owned By Institutions 93.41 %
- Number Of Shares Shorted 4.77 M
- Price To Earning 154.58 X
- Price To Book 4.86 X
- Price To Sales 14.99 X
- Revenue 638.76 M
- Gross Profit 455.71 M
- EBITDA 131.39 M
- Net Income 41.58 M
- Cash And Equivalents 596.51 M
- Cash Per Share 10.75 X
- Total Debt 711.8 M
- Debt To Equity 0.23 %
- Current Ratio 2.30 X
- Book Value Per Share 35.35 X
- Cash Flow From Operations 113.92 M
- Short Ratio 12.26 X
- Earnings Per Share 0.74 X
- Price To Earnings To Growth 2.59 X
- Target Price 204.62
- Number Of Employees 1.78 K
- Beta 1.01
- Market Capitalization 8.79 B
- Total Asset 2.82 B
- Retained Earnings 438.85 M
- Working Capital 952.88 M
- Current Asset 103.25 M
- Current Liabilities 18.78 M
- Net Asset 2.82 B
- Accumulation Distribution 47202.7
- Daily Balance Of Power 1.557562
- Rate Of Daily Change 1.09
- Day Median Price 169.87
- Day Typical Price 170.34
- Price Action Indicator 8.31
- Period Momentum Indicator 13.8
Market Snapshot Widget Example
DAX Index Germany | 18,138 1.55 | |
Taiwan Weighted Taiwan | 19,599 0.97 | |
PSI 20 Stock Portugal | 6,593 1.19 | |
CROBEX Croatia | 2,787 0.58 | |
Budapest SE Hungary | 65,939 1.25 | |
IDX 30 Jakarta Indonesia | 470.35 0.61 | |
ISEQ 20 Price Ireland | 1,646 0.39 | |
NYSE Comp USA | 17,793 1.08 | |
Tel Aviv 35 Israel | 1,912 0.55 | |
Coreshares Index Tracker South Afric | 1,041 1.46 | |
IPC MEXICO Mexico | 56,634 0.41 | |
KL Technology Malaysia | 63.18 0.78 | |
IBEX 35 Index Spain | 11,075 1.70 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,581 0.75 | |
SPASX Dividend Opportunities Australia | 1,656 0.07 | |
HNX 30 Vietnam | 481.21 2.96 | |
Bucharest BET-NG Romania | 1,205 0.23 | |
AMS Small Cap Netherlands | 1,189 0.52 | |
Oslo Exchange Mutual Norway | 1,291 0.09 | |
BEL Small Belgium | 9,020 1.28 | |
RTSI Index Russia | 1,164 0.75 | |
Basic Materials Brazil | 5,842 2.07 | |
Swiss Leader Price Switzerland | 1,870 1.24 | |
Fondo Mutuo ETF Chile | 1,420 0.97 | |
Athens General Comp Greece | 1,448 1.93 | |
Stock Exchange Of Thailand | 1,357 0.59 | |
PX Prague Stock Czech Repub | 1,551 0.42 | |
THE PHILIPPINE STOCK Philippines | 6,507 0.97 | |
WIG 30 Poland | 3,078 0.76 | |
BIST Electricity Turkey | 595.36 0.54 |
Investing Ideas
In addition to having Repligen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Repligen
Compare Repligen To Peers
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.Note that the Repligen information on this page should be used as a complementary analysis to other Repligen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Repligen Stock analysis
When running Repligen's price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Repligen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.55) | Earnings Share 0.74 | Revenue Per Share 11.464 | Quarterly Revenue Growth (0.17) | Return On Assets 0.0131 |
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.